Caricamento...
-
Benvenuto al sito EQAS
Neuroimmunological diagnostics has accelerated incredibly in recent years, thanks to the identification of many antibodies directed against neuronal and glial proteins, which represent fundamental markers for the diagnosis of neurological autoimmune diseases.
To identify the main critical issues of the Italian laboratories dedicated to neuroimmunological diagnostics, the Italian Association of Neuroimmunology (AINI) organized an external quality control (External Quality Assessment Scheme, EQAS) from various sources.
In 2023, AINI organized the most ambitious EQAS to date; 47 Italian and foreign laboratories have been included in the current EQAS, 16 more than in the 2022 EQAS.
EQAS Results
EQAS is organized with the non-conditional sponsorship of:
